Appointment of Independent Director Provides to Monetary Know-how on Board
Boca Raton, FL, Might 12, 2022 (Globe NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a enhancement-stage biomedical company targeted on novel treatments for scarce ailments and disorders, announced today that Cary Sucoff has joined its Board of Administrators as an impartial director. With in excess of 35 yrs of legal and securities field knowledge, Cary Sucoff has participated in the funding of over a person hundred community and personal firms and is presently on the boards of, or an advisor to, six health care and biotechnology businesses. Mr. Sucoff is an specialist in lawful, compliance, company system, and funds marketplaces and has chaired or sat on audit, compensation, nominating/governance, and special committees.
About Cary Sucoff
Given that 2011, Mr. Sucoff has owned and operated Fairness Supply Associates LLC, an advisory and consulting business. At present, Mr. Sucoff serves on the pursuing Boards of Administrators:
Contrafect Corp. – engaged in Phase 3 progress of new solutions for infectious conditions using proprietary antibody and lysin technologies (Audit Nom/Gov Pricing).
IMAC Holdings – offers motion and orthopedic therapies and minimally invasive processes carried out by means of regenerative and rehabilitative professional medical solutions delivered in non-public clinics and services inside Walmart stores. (Audit Nom/Gov Comp).
Galimedix Therapeutics, Inc. – know-how licensed from Tel Aviv College for perhaps innovative solutions for Glaucoma and Dry Age-relevant Macular Degeneration (Audit Nom/Gov).
First Wave Technologies, Inc. – new and progressive health-related gadget technologies focused on anesthesia and ventilator technologies (M&A).
In addition, Mr. Sucoff currently serves as an advisor to:
Sapience Therapeutics, Inc. – a Period 1/2 Biotech company concentrating on Glioblastoma.
LB Prescribed drugs – a NY-primarily based biotech firm developing a Section 2 novel drug to handle schizophrenia.
Kinetic Electric power Devices – an strength developer and producer of extensive length flywheel strength storage systems or mechanical batteries.
Mr. Sucoff, a former New York Town prosecutor, is the Past President of New England Legislation/Boston (Boston, Ma.) and is the senior member of its Board of Trustees where he has served for over 30 a long time. He has been Chairman of the Endowment Committee for in excess of 10 a long time and sits on the Finance Committee. Mr. Sucoff received a B.A. from SUNY Binghamton (1974) and a J.D. from New England College of Regulation (1977) the place he was the Managing Editor of the Law Assessment and graduated Magna Cum Laude. Mr. Sucoff has been a member of the Bar of the Condition of New York (now retired) considering the fact that 1978.
Foreseeable future Healing Biotechnology Press Releases and Updates
Fascinated buyers and shareholders can be notified of long term Push releases and Marketplace Updates by e-mailing [email protected]
About Curative Biotechnology, Inc. http://curativebiotech.com
Curative Biotechnology, Inc. (Curative Biotech) is a growth stage biomedical firm concentrated on novel therapies for unusual health conditions. The Company is focused on identifying, attaining and developing disorder modifying therapeutic drug candidates with a concentration on exceptional condition indications. Curative Biotech has ongoing courses in 3 unique therapeutic locations: infectious condition, neuro oncology and degenerative eye disorder. The Company’s pipeline contains IMT504, Control906 and Metformin Reformulation. IMT504 is a novel immune therapy to treat rabies and an adjuvant for vaccines. Suppress906 is a thoroughly humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate specifically to the tumor most cancers website to get rid of the tumor by inhibiting tumor advancement and migration of the tumor. Metformin Reformulation is concentrating on the treatment of intermediate and late-phase Age-Related Macular Degeneration (AMD) condition.
This press launch consists of “forward-seeking statements” in just the that means of Part 27A of the Securities Act of 1933, as amended, and Area 21E of the Securities Exchange Act of 1934. CUBT is not however generating revenues. Even though ahead-wanting statements in this release reflect the great religion judgment of management, forward-on the lookout statements are inherently subjected to recognized, unknown threats and uncertainties that may perhaps cause actual success to be materially distinct from those mentioned in these forward-on the lookout statements, together with but not constrained our potential to generate adequate market acceptance for our solutions and providers, our means to create adequate functioning dollars move, and typical financial conditions. Viewers are urged to diligently review and take into account the different disclosures created by us in our stories filed with OTC Markets from time to time which try to suggest interested events of the dangers and aspects that may possibly affect our business enterprise, financial issue, final results of procedure and dollars flows. If one or extra of these pitfalls or uncertainties materialize, or if the fundamental assumptions confirm incorrect, our real benefits may fluctuate materially from those predicted or projected. Audience are urged not to position undue reliance on these forward-looking statements, which discuss only as of the date of this release. We think no obligation to update any forward-seeking statements in order to replicate any party or circumstance that might occur soon after the day of this launch.
Make contact with:
Curative Biotech (CUBT)